secwatch / observer
8-K filed Jun 20, 2025 23:59 UTC CIK 0001808158
other_material confidence high sentiment neutral materiality 0.35

Repare Therapeutics amends severance benefits for EVP & CSO Michael Zinda

Repare Therapeutics Inc.

item 5.02
Source: SEC EDGAR
accession 0001193125-25-143639

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.